Literature DB >> 19497871

Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons.

Pascal E Sanchez1, Raafat P Fares, Jean-Jacques Risso, Chantal Bonnet, Sandrine Bouvard, Marion Le-Cavorsin, Béatrice Georges, Colette Moulin, Amor Belmeguenai, Jacques Bodennec, Anne Morales, Jean-Marc Pequignot, Etienne-Emile Baulieu, Robert A Levine, Laurent Bezin.   

Abstract

Erythropoietin receptor (EpoR) binding mediates neuroprotection by endogenous Epo or by exogenous recombinant human (rh)Epo. The level of EpoR gene expression may determine tissue responsiveness to Epo. Thus, harnessing the neuroprotective power of Epo requires an understanding of the Epo-EpoR system and its regulation. We tested the hypothesis that neuronal expression of EpoR is required to achieve optimal neuroprotection by Epo. The ventral limbic region (VLR) in the rat brain was used because we determined that its neurons express minimal EpoR under basal conditions, and they are highly sensitive to excitotoxic damage, such as occurs with pilocarpine-induced status epilepticus (Pilo-SE). We report that (i) EpoR expression is significantly elevated in nearly all VLR neurons when rats are subjected to 3 moderate hypoxic exposures, with each separated by a 4-day interval; (ii) synergistic induction of EpoR expression is achieved in the dorsal hippocampus and neocortex by the combination of hypoxia and exposure to an enriched environment, with minimal increased expression by either treatment alone; and (iii) rhEpo administered after Pilo-SE cannot rescue neurons in the VLR, unless neuronal induction of EpoR is elicited by hypoxia before Pilo-SE. This study thus demonstrates using environmental manipulations in normal rodents, the strict requirement for induction of EpoR expression in brain neurons to achieve optimal neuroprotection. Our results indicate that regulation of EpoR gene expression may facilitate the neuroprotective potential of rhEpo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497871      PMCID: PMC2701030          DOI: 10.1073/pnas.0901840106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Neural consequences of environmental enrichment.

Authors:  H van Praag; G Kempermann; F H Gage
Journal:  Nat Rev Neurosci       Date:  2000-12       Impact factor: 34.870

2.  Effects of environmental enrichment on gene expression in the brain.

Authors:  C Rampon; C H Jiang; H Dong; Y P Tang; D J Lockhart; P G Schultz; J Z Tsien; Y Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

Authors:  L C Schmued; K J Hopkins
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

4.  Production and processing of erythropoietin receptor transcripts in brain.

Authors:  K Chin; X Yu; B Beleslin-Cokic; C Liu; K Shen; H W Mohrenweiser; C T Noguchi
Journal:  Brain Res Mol Brain Res       Date:  2000-09-30

5.  Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus.

Authors:  L Covolan; L E Mello
Journal:  Epilepsy Res       Date:  2000-04       Impact factor: 3.045

6.  Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain.

Authors:  M Bernaudin; A Bellail; H H Marti; A Yvon; D Vivien; I Duchatelle; E T Mackenzie; E Petit
Journal:  Glia       Date:  2000-05       Impact factor: 7.452

7.  An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation.

Authors:  Orly Ravid; Imad Shams; Nathalie Ben Califa; Eviatar Nevo; Aaron Avivi; Drorit Neumann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

8.  Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.

Authors:  Hannelore Ehrenreich; Benjamin Fischer; Christine Norra; Felix Schellenberger; Nike Stender; Michael Stiefel; Anna-Leena Sirén; Walter Paulus; Klaus-Armin Nave; Ralf Gold; Claudia Bartels
Journal:  Brain       Date:  2007-08-29       Impact factor: 13.501

Review 9.  Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li; Yan Chen Shang
Journal:  Prog Neurobiol       Date:  2008-03-04       Impact factor: 11.685

10.  Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span.

Authors:  Pascal E Sanchez; Fabrice P Navarro; Raafat P Fares; Jérémie Nadam; Béatrice Georges; Colette Moulin; Marion Le Cavorsin; Chantal Bonnet; Philippe Ryvlin; Amor Belmeguenai; Jacques Bodennec; Anne Morales; Laurent Bezin
Journal:  J Comp Neurol       Date:  2009-06-01       Impact factor: 3.215

View more
  32 in total

1.  Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke.

Authors:  Damjan Osredkar; Jeffrey W Sall; Philip E Bickler; Donna M Ferriero
Journal:  Neurobiol Dis       Date:  2010-02-01       Impact factor: 5.996

2.  Neurotrophic paths in the treatment of depression.

Authors:  Shawn Hayley; Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

3.  Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats.

Authors:  R C Li; S Z Guo; M Raccurt; E Moudilou; G Morel; K R Brittian; D Gozal
Journal:  Neuroscience       Date:  2011-08-23       Impact factor: 3.590

Review 4.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

5.  Genetic compensation by epob in pronephros development in epoa mutant zebrafish.

Authors:  Jianqing She; Yue Wu; Bowen Lou; Elisabeth Lodd; Alina Klems; Felix Schmoehl; Zuyi Yuan; Ferdinand Le Noble; Jens Kroll
Journal:  Cell Cycle       Date:  2019-08-26       Impact factor: 4.534

6.  Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.

Authors:  Amalia Merelli; Laura Caltana; Patricia Girimonti; Alberto Javier Ramos; Alberto Lazarowski; Alicia Brusco
Journal:  Neurotox Res       Date:  2010-11-30       Impact factor: 3.911

Review 7.  Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

8.  Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.

Authors:  Jing Ding; Jing Wang; Qin-Ying Li; Jie-Zhong Yu; Cun-Gen Ma; Xin Wang; Chuan-Zhen Lu; Bao-Guo Xiao
Journal:  Mol Neurobiol       Date:  2016-08-19       Impact factor: 5.590

9.  Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease.

Authors:  Rudy Chang; Abrar Al Maghribi; Victoria Vanderpoel; Vitaly Vasilevko; David H Cribbs; Ruben Boado; William M Pardridge; Rachita K Sumbria
Journal:  Mol Pharm       Date:  2018-10-09       Impact factor: 4.939

10.  Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells.

Authors:  Stéphane Belin; Anne Beghin; Eduardo Solano-Gonzàlez; Laurent Bezin; Stéphanie Brunet-Manquat; Julien Textoris; Anne-Catherine Prats; Hichem C Mertani; Charles Dumontet; Jean-Jacques Diaz
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.